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Recognition of microbial danger signals by toll-like receptors (TLR) causes re-programming of
macrophages.To investigate kinasecascades triggeredbythe TLR4 ligand lipopolysaccharide(LPS)
on systems level, we performed a global, quantitative and kinetic analysis of the phosphoproteome
of primary macrophages using stable isotope labelling with amino acids in cell culture,
phosphopeptide enrichment and high-resolution mass spectrometry. In parallel, nascent RNA was
proﬁled to link transcription factor (TF) phosphorylation to TLR4-induced transcriptional
activation. We reproducibly identiﬁed 1850 phosphoproteins with 6956 phosphorylation sites,
two thirds of which were not reported earlier. LPS caused major dynamic changes in the
phosphoproteome (24% up-regulation and 9% down-regulation). Functional bioinformatic
analyses conﬁrmed canonical players of the TLR pathway and highlighted other signalling modules
(e.g. mTOR, ATM/ATR kinases) and the cytoskeleton as hotspots of LPS-regulated phosphorylation.
Finally, weaving together phosphoproteome and nascent transcriptome data by in silico promoter
analysis, we implicated several phosphorylated TFs in primary LPS-controlled gene expression.
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Introduction
Macrophages reside in all tissues and continuously sample their
environment by phagocytosis and endocytosis. They sense
invadingpathogensthroughpatternrecognitionreceptors(PRRs)
that bind common microbial structures. The best characterised
group of PRRs is the evolutionary conserved family of toll-like
receptors (TLRs), transmembrane proteins expressed on the cell
surface (e.g. TLR2,TLR4,TLR5)or in the endosome (e.g.TLR7–9)
(Takeda and Akira, 2004). Stimulation of macrophages in vitro
with the TLR4 agonist lipopolysaccharide (LPS) of Gram-
negative bacteria causes within a few hours substantial re-
programming of gene expression (Huang et al, 2001; Lang et al,
2002; Nau et al, 2002; Foster et al,2 0 0 7 ;M a g e set al,2 0 0 7 ) .T h i s
rapid response is pivotal for control of pathogen replication, and
includes production of chemokines, which recruit leukocytes to
the site of infection, anti-microbial effector molecules and
cytokinesthatinitiateandcontroltheadaptiveimmuneresponse.
After recognition of microbial ligands, TLR signalling
is initiated by binding of the adapter molecule MyD88 to
the cytoplasmic Toll/IL-1R domain present in all TLRs.
Recruitment of IL-1R-associated kinases (IRAK4, IRAK1)
and the adapter protein TNF-receptor-associated factor 6
triggers kinase cascades that result in activation of the MAPK
and NFkB pathways (Takeda and Akira, 2004). This core
pathway has been shown by many pieces of pharmacological
and genetic evidence, and controls gene expression by
activation of latent transcription factors (TFs) (e.g. NFkB
proteins and CREB family members) and by effects on mRNA
stability (Hao and Baltimore, 2009). Phosphorylation has an
essential role in TF activation: in the case of NFkB,
phosphorylation of the NFkB-bound inhibitor IkB by the IKK
complex is the ﬁrst step in the process leading to IkB
degradation, release of active NFkB and translocation to the
nucleus (Vallabhapurapu and Karin, 2009); CREB and IRF
family TFs form dimers after phosphorylation, enabling
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cytokine and chemokine genes (Honda and Taniguchi,
2006).
To avoid excessive inﬂammation, macrophage activation is
controlled by endogenous regulators, such as the immuno-
suppressive cytokine IL-10 (Lang, 2005; Liew et al, 2005).
Down-regulationisreﬂectedonthelevelofsignaltransduction
by the transient activation of key signalling modules. NFkB
signalling, for example, is down-regulated by re-synthesis of
IkB protein and export of NFkB from the nucleus (Vallabha-
purapuandKarin,2009).De-phosphorylationandinactivation
of MAPKs is brought about by members of the MAPK
phosphatase family, for example, by Dual speciﬁcity phospha-
tase 1 (DUSP1), that is induced by LPS in macrophages and
prevents excessive cytokine production by deactivating p38
MAPK (Chi et al, 2006; Hammer et al, 2006; Salojin et al, 2006;
Zhao et al, 2006).
TLR signalling has been extensively studied. A recent
review of TLR signalling compiled a network of 340 proteins
and 444 reactions involved in TLR signalling (Oda and
Kitano, 2006). However, a comprehensive analysis of
phosphorylation events in macrophages in response to TLR
stimulation is missing. A former study restricted to tyrosine
phosphorylation was further limited by its non-quantitative
nature and did not use primary cells (Aki et al, 2005).
Therefore, it is unknown (1) whether the canonical
pathwaysdescribedabovecomprisethemainphosphorylation
events, kinases and TFs for gene expression re-programming,
and (2) which other molecular functions and biological
processes are regulated by phosphorylation in LPS-activated
macrophages.
Recent progress in mass spectrometry-based proteomics
driven by leaps in instrument performance and advances in
computational proteomics has opened the possibility to
quantitativelyinvestigateglobalchangesinproteinabundance
and post-translational modiﬁcations (Cox and Mann, 2007).
Stable isotope labelling with amino acids in cell culture
(SILAC) allows mixing of samples before enrichment and
fractionation steps, and has proved especially useful for direct
comparison of phosphopeptide abundance in time course
or treatment analyses (Olsen et al, 2006; Kruger et al, 2008;
Pan et al, 2008).
Here, we combined SILAC, phosphopeptide enrichment and
high-accuracy mass spectrometry to analyse the phosphopro-
teome changes in resting versus LPS-activated primary bone
marrow-derived macrophages. We report the identiﬁcation of
nearly 7000 phosphorylation sites on more than 1800
phosphoproteins in macrophages, with a large fraction of
up-regulated and down-regulated phosphorylation sites in
response to LPS activation. Bioinformatic analyses found
enrichment of pathways associated with TLR signalling, in
addition revealed the cytoskeleton as a hotspot for phosphor-
ylation in macrophages, and highlighted other biological
processes and functions. In parallel, we analysed LPS-induced
de novo transcription by Affymetrix microarrays of puriﬁed 4-
thiouridine (4sU)-tagged RNA (‘nascent RNA’) (Dolken et al,
2008). By integrating TF phosphorylation with nascent
transcriptome data using in silico promoter analysis we
identiﬁed transcriptional regulators previously not implicated
in TLR-induced gene expression.
Results
Quantitative phosphoproteome analysis of
primary macrophages
Our global and quantitative analysis of phosphorylation sites
in macrophages builds on a previously described strategy
combining SILAC for quantiﬁcation, strong cation exchange
chromatography (SCX) and titanium dioxide (TiO2) chroma-
tography for phosphopeptide enrichment and high-accuracy
mass spectrometric characterisation (Olsen et al, 2006), which
we optimised for use with primary bone marrow-derived
macrophages (Figure 1A).
SILAC requires sufﬁcient time of cell culture for a full
labelling of all proteins with heavy isotope versions of
essential amino acids. We therefore adapted the standard
protocol for generation of bone marrow-derived macrophages
by inducing expansion of progenitor cells with the cytokines
IL-3, IL-6 and SCF in the presence of macrophage colony
stimulating factor (M-CSF). After expansion, cells were
differentiated into macrophages with M-CSF only
(Figure 1B). This 17-day protocol yielded large numbers of
cells (Figure 1C) and resulted in a high-labelling efﬁciency
(Figure 1D). Macrophages obtained by the standard or SILAC-
adapted protocol were comparable in terms of surface marker
expression (F4/80, CD11b), and responded equally to LPS
stimulation with activation of p38 MAPK and production of
inﬂammatory cytokines (Supplementary Figure S1).
Macrophages were SILAC encoded with both arginine and
lysine using three distinct isotopic forms. Pooling samples
from three different labelling conditions for further prepara-
tion ensures equal sample treatment and highly accurate
quantiﬁcation. Comparison of more than three conditions can
be achieved by including a common reference lysate in several
pools, which is used for calculation of phosphopeptide ratios.
Here, we analysed the phosphoproteome of macrophages in
response to LPS. Pools of lysates were prepared from WTand
Dusp1-deﬁcient macrophages stimulated with LPS for 15min
or 4h (Figure 1A). After fractionation, tryptic digest and
phosphopeptide enrichment, online liquid chromatography
tandem mass spectrometry (LC-MS/MS) was performed as
described in ‘Materials and methods’.
We reproducibly identiﬁed 6956 phosphorylation sites on
1850 proteins with single amino acid accuracy (according to
the PTM score; Olsen et al, 2006), more than 60% of which
were novel with respect to the phosphorylation site database
Expasy (containing all Swiss-Prot/TrEMBL entries; http://
www.expasy.ch) and a recent phosphoproteome study in the
mouse livercell line Hepa1-6 (Pan et al, 2008) (Supplementary
Table S1). The overlap between our two completely indepen-
dent experiments was 63–89%, depending on the experiment
referredto(Figure2A).Forbioinformaticanalyses,wefocused
on reproducibly identiﬁed phosphorylation sites, if not
indicated otherwise. Validation of phosphosites identiﬁed by
mass spectrometry can be done by immunoblotting in cases
where phosphorylation site-speciﬁc antibodies are available.
We conﬁrmed the regulated phosphorylation of GSK3b at S9
and ribosomal protein S6 at S235/236 (Supplementary Figure
S2), the phosphorylation of p38 MAPK (Mapk14) at T180 and
Y182 (Supplementary Figure S1) and of ERK1 MAPK (Mapk3)
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of ATF2 and TTP (Zfp36) at various residues was reﬂected by
the higher molecular weight bands observed for LPS-treated
samples in western blot analysis (Supplementary Figure S2).
We also conﬁrmed that macrophages grown using the SILAC
protocol were very similar to macrophages obtained with the
standard protocol under M-CSF, in extent and kinetics of
phosphorylation of ribosomal protein S6 and Stat1 (Supple-
mentary Figure S3). In accordance with previous reports from
othercellularsystems (Olsen et al, 2006; Villen et al, 2007; Pan
et al, 2008) most phosphorylation sites were on serine (84%)
and threonine residues (14%), whereas tyrosine phosphoryla-
tion occurred only in 2% of the cases (Figure 2B).
We detected phosphoproteins from all cellular compart-
ments. A comparison of the Gene Ontology (GO) annotation
for cellular component between the identiﬁed phosphopro-
teins and genes expressed in macrophages showed an overall
similar distribution (Figure 2C). As expected, extracellular
proteins were under-represented among phosphoproteins. We
also observed a relative paucity of proteins from the
mitochondria, ribosomes, endoplasmatic reticulum and lyso-
somes among phosphorylated proteins. This is in line with
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Figure 1 Experimental system and design. (A) Strategy for global and quantitative analysis of LPS-induced phosphorylation. Bone marrow cells from wild type (WT)
andDusp1-deﬁcient(KO)micewereSILACencodedwithnormalandstable isotope-substitutedarginineandlysineaminoacids,creatingthreestatesdistinguishableby
mass((m/z)mass/charge). Each populationwasstimulated withLPSfor 15minor4horleftun-treated. Unstimulatedwild-type cellswere includedinall threepools asa
common reference point. Cell lysates to be directly compared were pooled, fractionated and enzymatically digested into peptides, and phosphopeptides were enriched
on TiO2 beads and analysed by online LC-MS/MS. Owing to the mass shifts introduced by the SILAC amino acids mass spectra of labelled peptides revealed SILAC
triplets (same peptide from the three cell populations), with the intensities of the peaks reﬂecting the relative amounts of a peptide in the three conditions. This SILAC-
based approach allowed high-accuracy quantiﬁcation of phosphopeptides and, in most cases, localisation of the phosphate group with single amino acid accuracy. Two
independent experiments were performed. (B) Optimised protocol for SILAC of bone marrow-derived macrophages. (C) Cell proliferation under the SILAC protocol.
Total number of cells at different time points during SILAC labelling (mean±standard deviation from two independent experiments). (D) Labelling efﬁciency.
Representative peptide containing two arginine residues. The arrow indicates the position of partially labelled peptide.
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2006) and protein kinases expression (Pagliarini et al, 2008) in
the mitochondria. Surprisingly, the plasma membrane was
well represented among phosphoproteins. Of note, we
observed an over-representation of the terms ‘nucleus’,
‘chromosome’ and ‘cytoskeleton’ among phosphoproteins.
Dynamics of the phosphoproteome after TLR4
activation
We investigated changes in phosphorylation dependent on
LPS, time and the MAPK phosphatase DUSP1. Deletion of
DUSP1hadonlyasmallimpactonthephosphoproteome,with
o1.3% of all phosphopeptides hyper-phosphorylated in
resting and 2% in LPS-activated Dusp1-deﬁcient macrophages
(data not shown). However, in contrast to the strong and
reproducible effects of LPS in wild-type cells (see below),
we observed a high degree of variability between experiments
in Dusp1-deﬁcient macrophages. We therefore decided to
focus here on the effect of LPS on the phosphoproteome in
wild-type cells.
Stimulation with LPS strongly affected the phosphopro-
teome at both time points. Overall, phosphorylation of 24% of
all sites was up-regulated and of 9% was down-regulated
in response to LPS in wild-type cells (Figure 3A and B).
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and prolonged stimulation (Supplementary Figure S4). Ana-
lysis of the kinetic proﬁles (Figure 3C) revealed that the
phosphorylation status was sustained over time for only 36%
of up-regulated and 25% of down-regulated phosphorylation
sites(Figure3D, blackbars;Figure3C). Allothersiteschanged
their phosphorylation status over time (Figure 3D, light grey
bars; Figure 3C) or were detected at one of the time points only
(Figure3D),arguingagainst presenceattheothertimepointin
high amounts. Taken together, the changes in phosphorylation
were of a highly dynamic nature for a large fraction of
regulated phosphorylation sites.
Toestimatethecontribution ofLPS-inducedchangesin gene
expression to changes in phosphorylation, transcriptome
analyses were performed on macrophages cultured under
identical conditions and stimulated with LPS for 45min or
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regulated protein phosphorylation showed a stronger increase
in total mRNA levels (Figure 3E). At the late time point,
regulation of gene expression was more common, but more
than 90% of all up-regulated phosphorylation sites had a
stronger change in phosphorylation than in gene expression
(Figure3F),indicating thatchanges ingeneexpressionin most
cases do not account for the increased phosphorylation.
Kinase activity induced by LPS
Each of the phosphorylation sites identiﬁed here is the
substrate of one or more kinases. To obtain footprints of
kinase activation in response to TLR ligation, we searched the
phosphopeptide sequences for the known substrate speciﬁ-
cities of 33 human kinases (http://www.phosida.com), which
have been shown to match well with murine phosphorylation
sites (Pan et al, 2008), and determined motifs enriched among
LPS up-regulated compared to non-regulated phosphorylation
sites (Table I). Fifteen minutes after stimulation the strongest
over-representation was observed for the ERK/MAPK motif,
which is in accordance with the known role of the MAPK
module in TLR signalling. Other over-represented motifs were
associated with kinases recently described in the context of
TLR signalling: PKD has a role in TLR9 and TLR5 signalling
(Ivison et al, 2007; Park et al, 2009); activation of AKTand its
targets GSK3 and the mammalian target of rapamycin (mTOR)
have recently been shownin responseto TLR stimulation (Cao
et al, 2008; Schmitz et al, 2008); Ca
2þ-dependent activation of
CAMK2 is required for the expression of many LPS-target
genes (Liu et al, 2008). Other kinases, among them the DNA
damage-activated kinases ATM/ATR and the cell cycle-
associated kinases AURORA and CHK1/2, have not been
linked to the response to LPS. Many of the associated kinases
were expressed in macrophages and some had LPS-regulated
phosphorylation sites themselves potentially modulating
kinase activity (Table I). Interestingly, over-representation of
several motifs, including the ERK/MAPK motif, was also
observed for down-regulated phosphorylation sites (data not
shown), suggesting that TLR signalling also triggers down-
regulation of this type of phosphorylation by activation of
phosphatases or degradation of the phosphorylated proteins.
Association of LPS-regulated phosphoproteins
with signalling pathways and functional
annotation
To test whether TLR4-induced phosphorylation preferentially
targets speciﬁc signalling pathways and cellular processes, we
made use of two annotation systems: InnateDB, a database
integrating pathway information from several other sources
(http://www.innateDB.ca) and the GOSlim GO annotation
(http://www.geneontology.org/GO) for molecular functions
and biological processes.
We identiﬁed 48 phosphoproteins annotated as members of
the murine or human TLR, MAPK or NFKB signalling
pathways in InnateDB or on the innate immunity signalling
poster compiled by Latz and Fitzgerald (2008), 31 of which
showed LPS-regulated phosphorylation (Supplementary Table
S2). The pathway annotation ‘TLR signalling’ showed a trend
for enrichment among LPS-regulated phosphoproteins com-
pared to non-regulated phosphoproteins (odds ratio 2.4;
P-value 0.15). Signiﬁcant over-representation was found for
MAPKsignallingmembersandpathwaysrecentlydescribed as
activated downstream of TLRs, for example, the AKT and
mTOR pathways and the Rho GTPase cycle (Ruse and Knaus,
2006) (Table IIA; Supplementary Figure S5). GO analysis
showed enrichment of the terms ‘signal transduction’, ‘cell
communication’ and ‘kinase activity’ (Table IIB; Supplemen-
tary Table S3). Interestingly, functional annotation terms
associated with the cytoskeleton were also signiﬁcantly
enriched among LPS-regulated phosphoproteins. ‘Cell
Table I Kinases activated during TLR4 signalling
Time Motif Enrichment
(odds ratio)
Kinase expression Kinase phosphorylation
15min ERK/MAPK 3.7 Mapk1, 3, 4, 6-9, 11-15 Mapk3
a,6 ,9 ,1 0
a,1 4
a
ATM/ATR 3.5 Atm, Atr —
PKD 3.4 Pkd1, Pkdl1-3, Pkd2 —
CHK1 3.2 Chka
b, Chkb-cpt1b —
AURORA 2.5 Aurora-c, Aurkaip1 —
CAMK2 2.1 Camk2a, b, d, g, n1, n2 Camk2d, Camkk2
PLK 1.9 Plk1, 2
b,3 ,4 —
NEK6 1.7 Nek1-9 Nek3, 9
PKA 1.6 Prkaa1-2, -b1-2, -ca-b, -g1-3, -r1a-b, -r2a-b Prkaa1
a, -b1
a, -g2
a, r1a, -r2a, -r2b
CK1 1.6 Ckb, Ckm, Ckmt1-2 —
GSK3 1.6 Gsk3a, Gsk3b Gsk3a, Gsk3b
a
AKT (PKB) 1.4 Akt1, Akt2, Akt3, Akts1, Aktip Akt, Akt1s1, Aktip
4h PKD 2.0 Pkd1, Pkdl1-3, Pkd2 —
CHK1 1.9 Chka, Chkb-cpt1b —
ERK/MAPK 1.8 Mapk1, 3, 4, -6-9, 11-15 Mapk3
a, 6, 9, 10, 14
Kinase motifs (http://www.phosida.com) over-represented in LPS up-regulated compared to non-regulated phosphorylation sites (odds ratio X1.3 and corrected P-
value p0.05), suggesting kinase activation in response to LPS. Expression of associated kinases determined in the corresponding microarray experiments and
identiﬁcation of phosphopeptides from the kinases themselves are indicated by superscripts ‘a’ and ‘b’.
aPhosphorylation regulated (X1.5-fold) at the respective time point.
bExpression regulated (X2-fold).
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ratio 4.6; corrected P-value 0.12), consistent with over-
representation of motifs for cell cycle-associated kinases
observed above. In summary, unbiased statistical analyses of
kinase motifs, signalling pathways and functional GO annota-
tion highlighted known and novel players of TLR signalling
and linked TLR activation to the cytoskeleton and cell
proliferation (see overview in Figure 4).
To investigate the functional relevance of kinases (PI3K,
AKT, CAMK2, ATM, PKD, MEK1, mTOR) and pathways
(cytoskeletal rearrangement, Rho GTPases) enriched among
LPS-regulated phosphoproteins, we used a panel of pharma-
cological inhibitors and determined the expression of a set of
eightLPS-induciblegenes(Figure5AandB).InhibitionofAKT
and Rho had the strongest inhibitoryeffect. On the other hand,
inhibition of PI3K increased expression of IL-10, CCL-2 and
Fos, consistent with a regulatory role of PI3K in LPS-induced
gene expression (Fukao and Koyasu, 2003). Surprisingly,
pharmacological inhibition of the ATM kinase boosted the
mRNAlevelsof Fos,CCL-2,CXCL-10 and IL-10, especiallyafter
4.5h. The role of ATM in innate immune activation has not
beeninvestigatedbefore.Wethereforeconﬁrmedtheresults of
the inhibitor screen for ATM on the expression of IL-10, CCL-2
and CXCL-10 using additional concentrations of LPS and
inhibitor(Figure5C).ATMkinasemotifswereenrichedamong
LPS-regulated phosphorylation sites (Table I). By immuno-
blotting with an antibody recognising phosphorylated ATM
substrate proteins, we validated that LPS induced ATM kinase
activity (Figure 5D). Pharmacological ATM inhibition reduced
the intensity of ATM substrate phosphorylation, especially
when lower concentrations of LPS were used (Figure 5D).
Together, these data indicate a functional role of LPS-induced
ATM kinase activity in the negative regulation of a subset of
LPS-target genes.
Connecting TF phosphorylation with LPS-induced
transcriptional activation
One major function of signal transduction is regulation of gene
expression. Phosphorylation controls TF translocation, asso-
ciation with binding partners, binding to DNA or transcrip-
tional activation capacity (Karin, 1991). We detected 187
phosphoproteins annotated as transcriptional regulators
(Genomatix Matrix Library 7.1) with 668 phosphorylation
sites, 25% of which were regulated by LPS (Figure 6A).
We hypothesised that the frequencies of binding sites for
phosphorylated TFs may be increased in promoters of LPS-
regulated genes (Figure 6B). To identify transcriptionally
regulated genes with high sensitivity, we isolated nascent
RNA after metabolic labelling with 4-thiouridine during the
last 35min before cell harvest, as described recently (Dolken
et al, 2008). Microarray analyses of nascent RNA identiﬁed
substantially more probe sets as up-regulated after 45min
of LPS stimulation than parallel analyses of total cellular RNA
(Figure 6C–E). In contrast, 4.5h after stimulation, up-regulated
genes in total and nascent RNA largely overlapped (Figure 6E).
This approach therefore allowed a much more sensitive
detection of early changes in transcription, and the respective
genes are likely to be direct targets of LPS-regulated TFs.
In silico promoter scanning for binding sites for all 50 TF
families with phosphorylated members was used to test for
enrichment in transcriptionally induced genes. Forty-ﬁve
minutes after LPS, we found signiﬁcant over-representation
of binding sites for NFkB, an established mediator of LPS-
induced transcription; two other canonical LPS-activated TF
families, CREB and IRFF, showed a trend for enrichment (odds
ratio 1.3; corrected P-value 0.10 and 0.08, respectively).
Signiﬁcant enrichment for CEBP, MEF2, NFAT and HEAT
binding sites suggested a more genuine role for the associated
TFs, which have been described as activators of individual
LPS-target genes (Tanaka et al, 1995; Han et al, 1997;
Matsumoto et al, 1999; Zhu et al, 2003; Inouye et al, 2004,
2007). In addition, OCT1 and HOXC family members, which to
date have not been assigned a role in LPS-induced transcrip-
tion, were signiﬁcantly enriched (Figure 6F). In contrast,
analysis of promoters of genes induced in total cellular RNA
after 45min did not reveal any signiﬁcant over-representation
(data not shown). For IRFF, CEBP, MEF2, NFAT, OCT1, HOXC
over-representation was still observed at 4.5h in genes
regulated on nascent and total RNA levels (Figure 6Fand data
not shown), suggesting an enduring role for these factors,
whereas NFkB binding sites were not enriched any more.
Table II Signalling pathways, molecular functions and biological processes
targeted by LPS-regulated phosphorylation
Enrichment (odds ratio)
Overall 15min 4h
(A) Pathway name
MTOR signalling pathway 416.0 417.9 6.5
Adipocytokine signalling pathway 411.0 4 8.0
AKT phosphorylates targets in the cytosol 48.0 4 6.0
AKT (PKB)-Bad signalling 2.5
EGFR1 48.0
Caspase-mediated cleavage of
cytoskeletal proteins
48.0 8.5 7.8
TGF-b signalling pathway 47.0
TNF-a4 7.0
Insulin signalling pathway 3.0 2.6
MAPK signalling pathway 2.0
Rho GTPase cycle 2.8
Below cut-off
Toll-like receptor signalling pathway 2.4 1.4 3.3
(B) Gene ontology term
Signal transduction 3.1 2.6 1.9
Cell communication 2.8 2.6 2.1
Actin binding 2.3 2.9
Cytoskeletal protein binding 2.3 2.4
Kinase activity 1.7
Below cut-off
Cell proliferation 4.6 2.1 3.0
(A) Over-represented signalling pathways. Signalling pathways (http://www.
innateDB.ca; Lynnet al, 2008) with at least ﬁveidentiﬁed phosphoproteins were
analysed for over-representation among LPS-regulated phosphoproteins com-
pared to non-regulated phosphoproteins (odds ratio X1.3 and P-value p0.05;
below cut-off: P-value criterion not met, details see text). Depicted are over-
represented pathways that did not show more than 75% overlap with MAPK,
AKTand mTOR signalling.
(B) Over-represented Gene Ontology terms. Phosphoproteins were assigned to
GOSlim Gene Ontology terms for molecular functions and biological processes
(http://www.geneontology.org/GO), and over-representation among LPS-regu-
lated phosphoproteins compared to non-regulated phosphoproteins was
determined (odds ratio X1.3 and corrected P-value p0.05; below cut-off:
P-value criterion not met, details see text) for terms with at least three identiﬁed
phosphoproteins.
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binding site enrichment were LPS-regulated and more than
half of them have not been reported earlier (Figure 6F;
Supplementary Table S4). Although the technically complex
extraction of proteins from chromatin pellet fractions allowed
detection of several TF phosphorylation sites in one of the
experiments only, potential functional relevance was sug-
gested by the fact that most regulated sites are evolutionary
conserved (89 and 96% at 15min and 4.5h, respectively;
Supplementary Table S4), as are associated TF binding sites in
several of the top 20 LPS-induced target genes (selected
examples in Supplementary Figure S6).
Our in silico integration of phosphoproteome and nascent
transcriptome data conﬁrmed canonical and identiﬁed a
number of novel candidate TFs driving TLR-induced gene
expression. To obtain initial information about the involve-
ment of TFs with binding site enrichment in the expression of
LPS-target genes, we silenced expression of Cebpz (CEBP
matrix family), Hsf1 (HEAT), Atf7 (CREB) and Cic (SORY) in
primary macrophages using siRNA knockdown (Wiese et al,
2010) (Supplementary Figure S7A). Analysis of direct changes
in 128 critical TLR-regulated genes with the nCounter system
(Geiss et al, 2008; Amit et al, 2009) suggested Il1a and Il1b as
potential target genes (Supplementary Figure S7B). Indeed,
qRT–PCR conﬁrmed that the LPS-induced expression of Il1a
and Il1b was signiﬁcantly reduced when the novel TF CIC or
the CREB family member ATF7 was knocked down (Supple-
mentary Figure S7C). None of the TF knockdowns had a
signiﬁcant effect on Tnf expression (Supplementary Figure
S7C). These results validate our in silico identiﬁcation of CIC
and ATF7 as transcriptional regulators of the TLR pathway.
Future knockout investigations of these factors will address
the role of these and other enriched phosphorylated TFs in
innate immune function.
Discussion
This study provides the ﬁrst unbiased and quantitative
investigation of the macrophage phosphoproteome and
its dynamic changes in response to TLR activation. We
adapted an SILAC labelling approach to primary macrophages
that, coupled with TiO2-based phosphopeptide enrichment
and high-accuracy mass spectrometry, enabled us to repro-
ducibly identify and quantify a large number of serine,
threonine and tyrosine phosphorylation sites with high
conﬁdence. The substantial phosphoproteome regulation on
LPS stimulation is comparable in extent to the transcriptional
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Figure 4 The phosphoproteome of LPS-activated macrophages—overview. Hotspots of TLR4-induced phosphorylation at the level of pathways, kinases and
biological processes are summarised. Various signalling modules, cytoskeletal re-arrangement, cell cycle proteins and the translation machinery use the reversible
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Mages et al, 2007; data from this study), and reﬂects the
important role of phosphorylation cascades in TLR signalling.
Our parallel phosphoproteome and transcriptome analyses
underline the notion that widespread phosphorylation
precedes massive transcriptional changes; integration of these
two sets of systems level data by in silico promoter mapping
and TF binding site enrichment analysis identiﬁed phosphory-
lated TFs as candidate regulators of TLR-induced gene
expression.
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Figure 5 Pharmacological inhibition of LPS-activated pathways differentially impacts gene expression. (A) Induction of selected LPS-target genes. Strongly LPS-
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withRoche Universal Probe Library reagents inindependent experiments using total RNA from macrophages generated bythe standard protocol after 45min and 4.5h.
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gene expression. Macrophages were treated and analysed as in (A); the pharmacological inhibitors were added 2h before stimulation with LPS. Fold-changes induced
by LPS were calculated relative to the untreated samples using the DDCT method and subsequently normalised to the effect of LPS in the absence of inhibitor. The
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ATM inhibitor. After pretreatment with DMSO or ATM inhibitor (10mM) for 2h, macrophages were stimulated for 1h with LPS as indicated. Phosphorylated ATM
substrate proteins were detected with Cell Signaling antibody Cat. #2851.
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TLR-stimulated macrophages is evident from the kinetic
differences. Decreased phosphorylation in response to LPS,
or return of increased phosphorylation after an early
peak, may be caused by protein degradation or through
phosphatase activity. The M-CSF receptor is an example for
the ﬁrst mechanism, with decreases in a phosphorylated
peptide as well as in three non-phosphorylated peptides,
consistent with earlier reports on LPS- and IFNg-induced
M-CSF receptor degradation (Baccarini et al, 1992; Sester et al,
1999; Trost et al, 2009). Evidence for phosphatase activity is
provided by our observation that for many phosphoproteins
with a down-regulated site other phosphopeptides were
unchanged or increased. Progress in mass spectrometry
should allow to generate quantitative proteome data in the
near future to deﬁnitively determine which changes in
phosphorylation are inﬂuenced by differences in protein
levels (Cox and Mann, 2007). However, our parallel transcrip-
tome analysis already suggests that only a minor fraction of
induced phosphorylation results from increased expression
of the protein.
Hotspots of TLR-induced phosphorylation
Bioinformatic analyses of the regulated phosphorylation sites
and proteins for over-representation of kinase motifs and
functional annotation found the major canonical TLR-acti-
vated molecular players, including the kinases IRAK2, IRAK4,
MAPKs and upstream kinases,and the NFkB-activating kinase
IKKb, and revealed a number of less well appreciated and
novelsignalling components. Although we observed regulated
phosphorylation of many known TLR signalling components,
it should be noted that some established players (e.g. IRAK1;
IKBKE) were not detected in this screen. This observation
indicates that despite the reproducible identiﬁcation of nearly
7000 phosphorylation sites the screen is not yet saturated. In
addition, the time points chosen here may not ﬁt to the
phosphorylation kinetics of some pathway molecules such as
IRAK1 that is known to be phosphorylated early and then
degraded rapidly (Li et al, 2001; Kollewe et al, 2004); similarly,
the expected IFNb-induced Stat1 tyrosine phosphorylation
(Thomas et al, 2006) was observed by immunoblotting in
standard and SILAC-protocol macrophages with a strong peak
between 2 and 3h but nearly gone after 4h (Supplementary
Figure S3). The large fraction of new phosphorylation sites on
known pathway components (65%, Supplementary Table S2)
points to new regulatory aspects of TLR signalling. The
identiﬁcation of these trademark TLR pathway modules by
unbiased statistical testing strengthens the validity of our
experimental data, which are summarised in the form of a
model in Figure 6.
The PI3K/AKT pathway, together with its diverging down-
stream kinases GSK3 and mTOR, was prominently enriched
among LPS-regulated phosphoproteins. Ser9-phosphorylation
of GSK3 leads to increased production of IL-10 (Hu et al, 2006)
and may thereby mediate the described negative regulatory
role of PI3K/AKTactivation (Fukao and Koyasu, 2003). GSK3
kinase motif-bearing phosphoproteins identiﬁed here may
contribute to down-regulation of macrophage activity. On the
other hand, the strong enrichment of mTOR pathway proteins
highlights the importance of this pathway in innate immune
signalling, consistent with recent reports showing its impor-
tant role in IFN type I production (Cao et al, 2008), IL-10
expression (Ohtani et al, 2008; Weichhart et al, 2008) and
Stat3-dependent control of Caspase-1 (Schmitz et al, 2008).
How exactly mTOR controls these effects is unclear at present,
but an mTOR-dependent increase in translational efﬁciency is
involved in the regulation of IRF7 expression (Colina et al,
2008). Our observed phosphorylation of translation initiation
factors and of multiple ribosomal proteins after LPS may be
linked to mTOR activation.
Already 20 years ago, it was described that microbial
stimuli block macrophage proliferation (Hume et al, 1987).
The enrichment of the GO term ‘cell proliferation’ among
LPS-regulated phosphoproteins and evidence for activation of
the cell cycle relevant kinases ATM/ATR and CHK1/2 among
the LPS-regulated phosphorylation sites suggest a potential
phosphorylation-dependent mechanism for inhibition of
proliferation. ATM and ATR, usually activated by genotoxic
stress, phosphorylate the cell cycle checkpoint kinases Chk2
and Chk1, respectively (Abraham, 2001). Interestingly, the
p38-activated kinase mapkap kinase-2 (MK2) has a very
similar kinase motif and is a functional analogue of Chk1/2
(Manke et al, 2005); therefore, it is possible that the
enrichment for the CHK1/2 kinase motif observed here is the
footprint of LPS-induced, p38-dependent MK2-activation. A
functional role for ATM kinase in the negative regulation of
some LPS-induced cytokines is suggested by the effects of a
pharmacological ATM inhibitor on expression of IL-10, CCL2
and CXCL10. How exactly ATM kinase inﬂuences inﬂamma-
tory gene expression and which ATM substrate proteins
(Matsuoka et al, 2007) are phosphorylated in response to
TLR4 stimulation will be the subject of future studies.
That cytoskeletal and actin binding proteins are targeted by
TLR4-induced phosphorylation was unexpected, as the cytos-
keleton is usually not part of TLR pathway models (Oda and
Kitano, 2006). However, two key features of macrophages,
motilityandphagocytosis,dependoncytoskeletalremodelling
andareenhancedbyTLRstimulation(BlanderandMedzhitov,
2004; West et al, 2004) through MAPK-dependent pathways.
Rho family GTPases has a major role in actin remodelling
(Aderemand Underhill, 1999; Greenbergand Grinstein, 2002),
and we ﬁnd enrichment of the InnateDB pathway term ‘Rho
GTPase cycle’. Our identiﬁcation of multiple phosphorylation
sites on cytoskeletal proteins should be useful in the
investigation of cytoskeletal remodelling and phagocytosis.
The prominence of actin binding protein phosphorylation
could also indicate a genuine function of the cytoskeleton in
providing a platform for recruitment and spatial targeting of
signalling molecules; reversible phosphorylation could be a
control switch for this process.
Integration of TF phosphorylation and
transcriptional activation data
Here, we present the ﬁrst study integrating TF phosphorylation
and nascent transcriptome data through in silico promoter
analysis of binding site enrichment. At the early 45min time
point the majority of transcriptional changes probably repre-
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unbiased detection of these changes required the analysis of
nascent RNA (Dolken etal, 2008). Thisapproachconﬁrmed the
known role of NFkB and CREB TFs in early LPS-induced gene
expressionandoftheTrifdependence,lateractingIRFFTFs,but
in addition identiﬁed a number of less established (HEAT,
MEF2, CEBP, NFAT) and in the context of TLR-signalling new
transcriptionalregulators, suchasOCT, HOXC and SORY family
proteins.NFATisakeyTFinTcells;onlyrecently,arequirement
for NFAT activation in DC and macrophages was shown for
Dectin-1-dependent gene expression (Goodridge et al, 2007).
Ofnote,bindingofNFATc1toasiteintheIL-12p40promoterhas
been demonstrated after TLR stimulation (Zhu et al, 2003). Our
identiﬁcationofNFAT familyTFs with LPS-regulated phosphor-
ylation together with binding site enrichment in promoters of
TLR4-activated genes suggests a broader role for the calcineur-
in/NFAT pathway. In this context, our ﬁnding of pronounced
enrichment of the CAMK2 motif among LPS-regulated phos-
phoproteins is supported by recent reports showing LPS
triggered increase in Ca
2þ levels and activation of Camk2
(Liuetal,2008) andCa
2þ/calmodulin-dependentexpressionof
many LPS-target genes (Lai et al, 2009).
Computational approaches for the inference of transcrip-
tional networks from microarray gene expression have used a
combination of hierarchical clustering of time-course tran-
scriptome data and promoter motif scanning to associate TFs
with groups of co-expressed genes (Nilsson et al, 2006;
Ramsey et al, 2008). However, the fact that TF binding site
motifs usuallyarerecognised by morethan one TF proteinand
the tendency of TF binding sites to co-occur impede the
unambiguous identiﬁcation of the TF from enrichment
analysis. Furthermore, many TFs are regulated not on the
level of expression but post translationally, and are therefore
missed by these approaches. Our global phosphorylation data
on TFactivation in response to LPS help to ﬁll these gaps and
allowed us to implicate novel phosphorylated regulators of
macrophage transcriptional responses. This approach recog-
nisedthebestcharacterisedLPS-activated TFs inmacrophages
(NFkB, CREB) and identiﬁed the recently reported regulatory
TFCEBPD(Litvaketal,2009)asenriched.Importantly,siRNA-
mediated knockdown of the CREB family TFATF7 and of the
SORY binding protein CIC demonstrated a non-redundant
contribution of these phosphorylated TFs in the LPS-induced
expression of Il1a and Il1b (Supplementary Figure S7). This
experimental validation of a functional role for ATF7 and
CIC makes us conﬁdent that also other enriched phosphory-
lated TFs identiﬁed here will be veriﬁed as true regulators of
LPS-induced transcription in ongoing studies.
Conclusion
Taken together, this study provides a new, global perspective
on innate immune activation by TLR signalling. We quantita-
tively detected a large number of site-speciﬁc phosphorylation
events, which are now publicly available through the Phosida
database (http://www.phosida.com). By combining different
data mining approaches, we consistently identiﬁed canonical
and novel TLR-activated signalling modules. In particular, the
PI3K/AKT and the related mTOR pathway were highlighted;
furthermore, DNA damage–response-associated ATM/ATR
kinases and the cytoskeleton emerged as unexpected hotspots
for phosphorylation. Finally, weaving together corresponding
phosphoproteome and nascent transcriptome datasets
through the loom of in silico promoter analysis we identiﬁed
several TFs acting at the intersection of TLR-induced kinase
activation and gene transcription.
Materials and methods
Mice, SILAC of bone marrow-derived
macrophages
Wild-type and Dusp1-deﬁcient mice on a C3H/HeN background were
bred under pathogen-free conditions at the animal facility of the
Institute of Medical Microbiology, Immunology and Hygiene at
Technische Universita ¨tM u ¨nchen, Germany. Bone marrow cells were
isolated and cultured in SILAC medium for 17 days: After overnight
depletion of adherent cells non-adherent cells were expanded by
addition of recombinant murine IL-3 (10mg/l), IL-6 (10mg/l) and SCF
(50mg/l) (Tebu-Bio) in the presence of 10% L-cell conditioned
medium (LCCM) as a source of M-CSFon 10cm bacteriological plates,
starting with 1 10
7 cells per plate. These cytokines have a role in
macrophage development in vivo (Metcalf, 1997) and have been used
to stimulate proliferation of bone marrow cells for retroviral infections
(Holst et al, 2006). M-CSF was included in the cultures from the
beginning to favour the differentiation of macrophages. Cultures were
split every 2–3 days. After 13 days, cells were plated in medium with
10% LCCM without cytokines to complete differentiation into
macrophagesfor 3 days. On day16, non-adherent cells were discarded
and 25 10
6 adherent cells were plated on 15cm cell culture plates
(Falcon) without LCCM for stimulation the next day. Details on the
splitting procedure are given in Supplementary information.
SILAC medium
Dulbecco’s modiﬁed Eagle’s medium with stable glutamine deﬁcient
in L-arginine and L-lysine (custom made, Biochrom AG), supple-
mented with 1% penicillin/streptomycin (Biochrom AG), 0.1%
2-mercaptoethanol (Gibco), 10% dialysed fetal bovine serum (Gibco),
84g/l L-arginine HCl labelled with
13C6 (Arg ‘6’) or
13C6
15N4 (Arg ‘10’),
146g/l L-lysine HCl labelled with
2D4 (Lys ‘4’) or
13C6
15N2 (Lys ‘8’)
(EurisoTop GmbH) or their non-labelled counterparts (Arg ‘0’ and Lys
‘0’) (Sigma Aldrich). Thirty g/l non-labelled L-proline (Sigma Aldrich)
was added to reduce conversion of labelled arginine to proline (o5%,
data not shown).
Stimulation, cell lysis, fractionation
and phosphopeptide preparation
Per condition, 50 10
6 SILAC-encoded macrophages were left un-
treated or stimulated with 100ng/ml Escherichia coli LPS (Sigma
Aldrich) for 15min or 4h. Cells were washed with PBS, lysed in ice-
cold modiﬁed RIPA buffer for 15min and scraped. Lysates were
pooled, vortexed for 2min and centrifuged to separate soluble and
chromatin pellet fractions (17000g, 15min).
The soluble fraction was precipitated overnight at  201C by adding
4 volumes of ice-cold acetone. The acetone precipitate was
re-solubilised in 8M urea (6M urea/2M thiourea, Sigma Aldrich).
Reduction, alkylation, enzymaticdigest in-solution and SCX of soluble
protein mixtures were performed essentially as described (Olsen et al,
2006). Proteins from the insoluble chromatin pellet were extracted by
DNA digest with benzonase (Merck) and re-solubilisation in 8M urea
followed by incubation with loading dye under rotation at 951C for
5min. Proteins were reduced and alkylated, resolved by SDS–PAGE on
a gradient gel (4–15% Tris–HCl Ready Gel Precast Gel, Bio-Rad),
stained with Coomassie and digested in situ essentially as described
(Shevchenko et al, 2006). From all fractions, phosphopeptides
were enriched on TiO2 beads (GL Sciences, Japan) in the presence of
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Details are given in Supplementary information.
Modiﬁed RIPA buffer
One Percent Igepal CA-630, 0.1% sodium deoxycholate, 150mM
sodiumchloride,1mMEDTA,50mMTris(pH7.5),supplementedwith
1mM sodium ortho-vanadate, 5mM sodium ﬂuoride and 5mM
b-glycerophosphate for inhibition of phosphatases and complete
protease inhibitors (Roche Applied Science) directly before use.
Mass spectrometric analysis
Phosphopeptide mixtures were analysed by online nanoﬂow LC-MS/
MS as described earlier (Olsen et al, 2006) with a few modiﬁcations.
All LC-MSanalysis were performedwith2h gradientson an EASY-nLC
system (Proxeon Biosystems) directly coupled to an LTQ-Orbitrap XL
instrument (Thermo Electron) that was operated in the data-
dependent acquisition mode to automatically switch between orbitrap
full scan MS and LTQ MS/MS using a top10 method. Raw ﬁles were
analysed and quantiﬁed using the MaxQuant software suite (Cox and
Mann,2008), peptides were identiﬁed byMascot and ﬁltered for o1%
false discovery rate (FDR) in MaxQuant. Phosphorylation sites
were localised inside the identiﬁed peptide sequences using the PTM
score algorithm (Olsen et al, 2006). Phosphopeptide ratios were
calculated, referring to unstimulated wild types were calculated for
each genotype and time point, and were normalised such that the
median of log-transformed ratios of all identiﬁed peptides was zero, to
correct for unequal sample mixing. Speciﬁc details on the MS
acquisition and the downstream analysis are given in Supplementary
information. The phosphoproteome dataset is also accessible in the
Phosida database (http://141.61.102.18/phosida/speciﬁcprojects/
login.aspx?project¼219&).
Metabolic labelling, puriﬁcation and analysis
of nascent RNA
Metabolic labelling and puriﬁcation of nascent RNA were performed
essentiallyas described(Dolken et al, 2008), withminor modiﬁcations
for use with primary macrophages that are described in Supplemen-
tary information. The microarray dataset has been deposited as series
GSE20674 in the Gene Expression Omnibus database and can be
accessed at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼
GSE20674.
Bioinformatic analyses
Contaminating FCS and human keratin proteins were excluded as
described in Supplementary information. Analyses on the phospho-
protein level were performed on all phosphorylated proteins, regard-
less of the probability for right localisation of the phosphate group
within a peptide according to the PTM score developed by Olsen et al
(2006) (note that the likelihood that such a peptide is phosphorylated
is still X99%). Analyses on the phosphorylation site level included
only sites for which the phosphate group could be located within the
peptide with single amino acid accuracy (class I sites).
Contribution of gene expression changes to regulation
of the phosphoproteome
Changes in gene expression at the level of total cellular RNA were
correlated with changes in phosphorylation for all proteins with LPS
up-regulated phosphorylation (log2 ratio of mean fold-changes from
two independent experiments). If several probe sets existed for one
gene, the probe set with the highest expression value was selected. For
35 proteins with LPS up regulated phosphorylation no corres-
ponding probe set was found or RNA expression was not above
background level.
GO analysis
Although most GO analysis tools calculate an over-representation of
GO terms over the genomic background we developed a strategy for
direct comparison of different lists against each other: Numbers of
phosphoproteinsassociatedwitheachGOtermweredeterminedusing
the GO Browser in Spotﬁre Decision Site (Tibco), the generic GOSlim
ontology ﬁle (OBO-Edit version 1.101) and the GO annotation ﬁle for
mouse (version 11/7/2008), downloaded from http://www.geneonto-
logy.org/GO. To determine statistically signiﬁcant over-representation
of terms, odds ratio ((number of matches list A/number of non-
matches list A)/(numberof matcheslist B/numberofnon-matcheslist
B)) and Fisher’s exact probability using the R Statistics package
(http://www.r-project.org) were calculated for each GO term,
comparing proteins with LPS-regulated and non-regulated phosphor-
ylation sites. P-values were corrected for multiple testing using the
Benjamini–Hochberg method for controlling FDR (Benjamini and
Hochberg, 1995). Only GO terms with at least three identiﬁed
phosphoproteins were analysed. GO terms with an odds ratio X1.3
or p0.67 and a corrected P-value p0.05 were considered signiﬁcant.
Kinase motifs
Phosphorylation sites were matched to the known substrate speciﬁ-
cities (linear sequence motifs) for 33 human kinases (http://
www.phosida.com). To determine statistically signiﬁcant over-repre-
sentation of a motif among LPS-induced phosphorylation sites the
number of sites that matched the pattern was determined among LPS-
induced phosphorylation sites and among phosphorylation sites that
were not up-regulated in response to LPS. Odds ratios and Fisher’s
exact probabilities, which were corrected for multiple testing, were
calculated as described for the GO analysis. Motifs with an odds ratio
X1.3 and a corrected P-value p0.05 were considered signiﬁcant.
All enriched kinase motifs matched at least 10 phosphorylation sites.
Signalling pathways
Phosphoproteins were assigned to signalling pathways through
ENSEMBL identiﬁers using InnateDB (Lynn et al, 2008) (http://
www.innateDB.ca, version 29/1/2009), which provides pathway
annotation from many different databases and calculates over-
representation over the genomic background. For a direct comparison
of LPS-regulated and not LPS-regulated phosphoproteins, the number
of phosphoproteins associated with each pathway was determined
with InnateDB, and odds ratio and Fisher’s exact probability were
calculated as described for the GO analysis. Only pathways for which
we identiﬁed at least ﬁve phosphoproteins were included in the
analysis. Signalling pathways with an odds ratio X1.3 and a P-value
p0.05 were considered signiﬁcant.
Gene symbols of over-represented signalling pathways were
extracted from InnateDB and loaded into the database STRING 8.0
(Jensen et al,2009)(http://string.embl.de)forextraction offunctional
interaction networks. Reported interactions include direct (physical)
and indirect (functional) interactions based on experimental evidence
from high-throughput studies, co-regulation of gene expression, same
genomic context or co-citation in the literature. Pathway networks
were visualised with Cytoscape v.2.6.2 (http://www.cytoscape.org).
Only interactions with a minimum STRING combined score of 0.400,
which represents the default medium conﬁdence level in STRING,
were kept.
TF binding sites
To determine over-represented TF binding sites in LPS-regulated
promoters, promoter sequences of LPS-induced genes (X3-fold) and
of genes not regulated by LPS (2000 probe sets with the least
regulation; to minimise background noise, only probe sets with
GeneID and a maximal expression value of at least 50) were retrieved
with Genomatix Gene2Promoter through GeneIDs (http://www.geno-
matix.de, large-scale option, database version ElDorado 07-2008) and
searched for the presence of binding sites for 50 TF families with
phosphorylated members, with Genomatix RegionMiner (http://
www.genomatix.de, matrix library version 7.1). RegionMiner deter-
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with a binding site, not the numberof binding sites within a promoter)
and calculates over-representation over the genomic background.
To determine binding site over-representation in promoters of LPS-
regulated genes compared to promoters of genes not regulated by LPS,
we calculated odds ratios and Fisher’s exact P-values, which were
corrected for multiple testing, as described for the GO analysis.
TF families with an odds ratio X1.3 and a corrected P-value p0.05
were considered signiﬁcant.
To determine evolutionary conservation of TF binding sites, the
promoters of the 20 most strongly induced genes in nascent RNA
(45min, ranked mean fold-change from two independent experi-
ments) were compared to orthologous vertebrate promoters (retrieved
with Genomatix Gene2Promoter, database version ElDorado 12-2009)
with Genomatix MatInspector (Cartharius et al, 2005), and similar
positions of TF binding sites relative to the transcriptional start sites
were determined by eye in Genomatix-aligned promoters.
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (http://www.nature.com/msb).
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